Skip to content Accessibility statement

Cancer and infections in sub-Saharan Africa

Working in collaboration with the UK Medical Research Council-funded Unit, based in Entebbe, Uganda, our work focusses primarily on understanding modifiable risk factors for cancer in sub-Saharan Africa (SSA), with the ultimate goal of facilitating cancer prevention.

There are a number of other centres in Africa conducting cancer research. However, almost all of these programmes are hospital/clinic-based whereas our particular contribution is to leverage the power of population-based research using the Unit’s General Population Cohort (GPC). Within this framework, we have shown that cancer is the most significant cause of non-communicable disease (NCD) deaths in rural Uganda (>33% of NCD deaths and >15% of all deaths) and that cancer-causing infections are amongst the most important risk factors for NCDs in the region. Hence, the majority (but not all) of our activity relates to cancer-causing infections.

Main projects

In response to the COVID-19 pandemic some of our work was temporarily suspended, but, with support from the MRC we established one of the most comprehensive epidemiological studies of SARS-CoV-2 in Africa.
Population-based multidisciplinary work on Kaposi’s Sarcoma associated Herpesvirus (KSHV) is a cornerstone of our activity and is unique on the continent. Kaposi’s Sarcoma (KS) remains one of the most common cancers in sub-Saharan Africa (SSA), and the underlying necessary cause (KSHV), is highly prevalent.
We conduct novel research on haematological malignancies/abnormalities in Africa that links to activity in the UK. It is changing long-held paradigms concerning the geographical distribution of disease and is enhancing our understanding of pathophysiology, including for the common childhood cancer Burkitt lymphoma.
We have developed strong collaborations for the study of important cancer-causing infections in Uganda: Human papillomavirus (HPV), Helicobacter pylori and Hepatitis Viruses. Much of this work has evolved into significantly larger multi-country investigations.